Ex-Stryker Corporation Exec Dodges Jail In Insider Trading Scheme

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Former Stryker executive Mark Foldy, who pleaded guilty last year for his part in an insider trading scheme, dodges a jail sentence. A former Stryker (NYSE:SYK) marketing executive escaped a jail sentence yesterday, instead drawing 6 months of home confinement and 2 years of probation for passing along inside information ahead of Stryker's 2011 acquisition of Orthovita. Last week a pair of traders were sentenced to jail for their parts in the scheme, after admitting to illegal stock trades based on tips relayed from Mark Foldy, a former marketing executive at Stryker.

Help employers find you! Check out all the jobs and post your resume.

Back to news